Clinical Trials

Explore the latest mcg Studies

Ongoing Trials

Use of Magnetocardiography in Evaluation of Patients Going for Cardiac Catheterization (NCT04044391)

This is a multicenter, prospective trial to measure the test performance characterisitics of the Magnetocardiography (MCG) CardioFlux cardiac diagnostic system in detecting clinically significant coronary atrery obstruction in patients with symptoms of suspected acute coronary syndrome or who present with a failed stress test with the intention to treat with cardiac catheterization.

Role of CardioFlux in Predicting Coronary Artery Disease (CAD) Outcomes (NCT03968809)

This single-center clinical trial is designed to evaluate the CardioFlux magnetocardiograph diagnostic imaging system to predict major adverse cardiac events (MACE) in patients referred to outpatient evaluation for coronary artery disease.

Completed Trials

Magnetocardiography Using a Novel Analysis System (CardioFlux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients (NCT03255772)

Genetesis is a cardiac diagnostics company which presents a novel magnetocardiogram (MCG) analysis system called CardioFlux. This investigation presents a new, noninvasive diagnostic option to use MCG for rapid diagnosis of acute coronary syndrome. Data from the CardioFlux system was compared with stress testing methods as well as the results of cardiac catheterization to identify patients with myocardial ischemia.

This was a prospective observational single-blinded convenience pilot study of 101 patients placed in the Clinical Decision Unit (CDU) for evaluation of chest pain at St. John Hospital and Medical Center (Detroit, MI).

Patients enrolled in the study also had a 30 and 180 day follow up for analysis of adverse cardiac events.